Response and Adherence to Nilotinib in Daily Practice
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2018
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms RAND
- 03 Oct 2018 Status changed from recruiting to discontinued.
- 25 Aug 2014 According to Netherlands Trial Registry record, Status changed from not yet recruiting to recruiting.
- 28 May 2013 New trial record